Trials / Completed
CompletedNCT03366948
Internet Gaming Disorder and Psychiatric Disorder
Internet Gaming Disorder Prevalence of Teenager Psychiatric Inpatient of 4 Psychiatric Units of French Region Auvergne-Rhône-Alpes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) recently identified Internet gaming disorder as a new potential psychiatric disorder which need further research. Several studies showed the important prevalence of psychiatric disorders among patients suffering from internet gaming disorder. Investigators hypothesize that on an other side the prevalence of internet gaming disorder among patients suffering from psychiatric disorders shall be high but it has never been studied yet. The main goal of this trial is to examine the prevalence of internet gaming disorder using the Internet Gaming Disorder Test-10 (IGDT-10) among inpatient aged from 12 to 17 of 4 psychiatric units of French region Auvergne-Rhône-Alpes. Secondary goals will be to assess a parental version of the IGDT-10 (IGDT-10-P) and to compare the two versions. IGDT-10 will be passed during 6 months to every inpatient and IGDT-10-P to their parents within the 21 first days of the hospitalisation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | IGDT-10 self-administered questionnaire | Patients and their parents will answer the French version of the IGDT-10 self-administered questionnaire (IGDT-10-P in the parents 'questionnaire). The IGDT-10 is a self-administered questionnaire based on DSM-5 internet gaming disorder criteria and the IGDT-10-P is a parental version specially adapted from the IGDT-10 for this study. |
Timeline
- Start date
- 2018-03-16
- Primary completion
- 2018-09-14
- Completion
- 2018-09-14
- First posted
- 2017-12-08
- Last updated
- 2019-08-13
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03366948. Inclusion in this directory is not an endorsement.